DiabetologyNews.net

Diabetology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Xagena Salute

The objective of a study was to characterize associations between initiation of Metformin and sulfonylurea therapy and clinical outcomes among patients with comorbid heart failure ( HF ) and diabetes ...


The FDA ( Food and Drug Administration ) has approved Mounjaro ( Tirzepatide ) injection, new once-weekly GIP ( glucose-dependent insulinotropic polypeptide ) and GLP-1 ( glucagon-like peptide-1 ) re ...


Hyperkalaemia is a common complication of type 2 diabetes mellitus ( T2DM ) and limits the optimal use of agents that block the renin-angiotensin-aldosterone system, particularly in patients with chro ...


Canagliflozin has reduced the risk of heart failure among patients with type 2 diabetes in the CANVAS Program. The mechanism of protection is uncertain. A study has explored potential mediators of ...


Since December 2019, a pneumonia caused by SARS-CoV-2 which was later named as COVID-19 emerged and many people lost their lives in Wuhan, China. Diabetes is a common comorbidity in patients with C ...


The aim of study was to investigate the efficacy, safety, and tolerability of oral Semaglutide ( Rybelsus ) added to Insulin with or without Metformin. Patients with type 2 diabetes uncontrolled on ...


The purpose of the study was to explore potential mediators of the effects of Canagliflozin ( Invokana ) on heart failure in the CANVAS Program ( CANagliflozin cardioVascular Assessment Study and CANa ...


Diabetes confers a greater excess risk of heart failure in women than men, according to new research in Diabetologia, the journal of the European Association for the Study of Diabetes. Type 1 diabet ...


A new study has found that three quarters of individuals with type 2 diabetes ( T2D ) who were treated with obesity surgery known as Roux-en-Y gastric bypass surgery ( RYGB ) experienced diabetes remi ...


A daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases ( NID ...


A treatment affecting the immune system effectively has slown the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded rese ...


People with undetected glucose disorders run a higher risk of both myocardial infarction and periodontitis, according to a study published in the journal Diabetes Care by researchers at Karolinska Ins ...


Results of a new subgroup analysis from the phase 3 CREDENCE study, showing Canagliflozin ( Invokana ) has significantly reduced the risk of major cardiovascular ( CV ) events and kidney failure in pa ...


A study has assessed the efficacy and safety of iGlarLixi ( a titratable, fixed-ratio combination of Insulin glargine [ iGlar ] plus Lixisenatide ) in older patients with type 2 diabetes. The post ...


A study has investigated the association of diabetic retinopathy and neuropathy with increased risk of recurrent cardiovascular events in 6068 patients with type 2 diabetes mellitus ( T2DM ) and recen ...